Article
AstraZeneca And Daiichi Sankyo's Enhertu Approved In EU For Advanced Breast Cancer Treatment
Neutral
0.0
−100 Bearish
0
+100 Bullish
(RTTNews) - AstraZeneca Plc. (AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) Enhertu (trastuzumab deruxtecan) has been approved in the European Union as a treatment for adults with advanced breast cancer. It is for patients with unresectable or metastatic hormone receptor (HR)-posit
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Source
NASDAQ Markets
Published
Apr 4, 2025 · 6:19 am
Article ID
83036660853539205267
Original URL
Open source
Sentiment Signal
Neutral
0.0
−100Neutral+100
More Like This